Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply
1996

Effects of Nifedipine on Bryostatin 1 Muscle Toxicity

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): CH Thompson, VM Macaulay, KJ O'Byrne, GJ Kemp, SM Wilner, DC Talbot, AL Harris, GK Radda

Primary Institution: MRC Biochemical and Clinical Magnetic Resonance Unit, Oxford Radcliffe Hospital, Oxford, UK

Hypothesis

Does nifedipine mitigate the muscle toxicity caused by bryostatin 1?

Conclusion

Nifedipine did not reduce the clinical toxicity of bryostatin 1, which is likely not due to vasoconstriction.

Supporting Evidence

  • Nifedipine impaired muscle oxidative metabolism but did not affect proton efflux or muscle reoxygenation rate.
  • Two effects of bryostatin were abolished in the presence of nifedipine, but impaired mitochondrial activity remained.
  • Nifedipine did not allow a greater number of bryostatin courses to be administered.

Takeaway

This study looked at whether a medicine called nifedipine could help reduce muscle pain caused by another medicine called bryostatin. It found that nifedipine didn't help with the pain.

Methodology

The study used 31P magnetic resonance spectroscopy and near infrared spectroscopy to assess muscle metabolism and reoxygenation in patients with melanoma receiving bryostatin and nifedipine.

Limitations

The study had a small sample size and did not assess the effects of nifedipine on mitochondrial function in detail.

Participant Demographics

Six physically active patients with malignant melanoma.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication